LinkedIn Twitter
CONTACT
Español|English
Ir al contenido [alt + 0]

Group Group 12

Group 12

COMUNIDAD AUTÓNOMA

Comunidad Valenciana

Nodo: Valencia

CENTER:

Centro Superior de Investigación en Salud Pública (CSISP)

MAIN RESEARCHER:

Isabel Hurtado Navarro

GROUP CODE:

RD16/0001/0011

CONTACT ADDRESS:

hurtado_isa@gva.es

CSISP-FISABIO Research Group of Health Services Research on Chronic Diseases

Nodo Comunidad Valenciana
Dirección: Avenida de Cataluña 21, 46020 Valencia
Email: librero_jul@gva.es; peiro_bor@gva.es
Teléfono: +34 961-925916
Fax: +34 961-925703
Web: http://www.csisp.gva.es/inicio

Group description

Multidisciplinary group coordinated by Dr. Isabel Hurtado Navarro, formed by 10 researchers: (doctors, pharmacists, psychologists, economists, dentists, nurses, engineers, biologists) of the Research Unit in Health Services in Chronic Diseases of CSISP-FISABIO of the Hospital Universitario and Politécnico de la Fe and Universidad Politécnica de Valencia.

Main research lines include: 1) health utilization and medical practice variations, 2) Risk adjustment methods for the assessment of the comparative effectiveness using routine health information systems, 3) pharmacoepidemiology and drug utilization studies, 4) outcomes research including health related quality of life and cost-effectiveness analysis.

Most relevant products

• The development and following of the ESOSVAL cohort to asses risk factors for osteoporotic fracture (PS09/02500; PI11/00238).
• The analysis of medical practice variation in the Spanish NHS and Europe (PI06/1673, PI10/00494, UE Agreement 242189).

Publications

• Myers JA, Shrank WH, Pakes J, Sanfélix-Gimeno G, Matlin O, Brennan TA, Choudhry NK. Group-based trajectory models accurately summarized observed patterns of medication adherence. Med Care. 2013; In press
• Sanfélix-Genovés J, Sanfélix-Gimeno G, Peiró S, Hurtado I, Fluixà C, Fuertes A, Campos JC, Giner V, Baixauli C. Prevalence of osteoporotic fracture risk factors and antiosteoporotic treatments in the Valencia region, Spain. The baseline characteristics of the ESOSVAL cohort. Osteoporos Int. 2013;24(3):1045-55.
• Sanfélix-Gimeno G, Sanfélix-Genovés J, Rodriguez-Bernal CL, Peiró S, Hurtado Prevalence, determinants and inappropriateness of calcium supplementation among men and women in a Spanish Mediterranean area. Cross-sectional data from the ESOSVAL cohort. J Bone Mineral Res. 2013. In press.
• Catalá-López F, Alonso-Arroyo A, Aleixandre-Benavent R, Ridao M, Bolaños M, García-Altés A, Sanfélix-Gimeno G, Peiró S. Coauthorship and institutional collaborations on cost-effectiveness analyses: a systematic network analysis. PLoS One. 2012;7(5):e38012.
• Catalá-López F, Sanfélix-Gimeno G, García-Torres C, Ridao M, Peiró S. Control of arterial hypertension in Spain: a systematic review and metaanalysis of 76 epidemiological studies on 341 632 participants. J Hypertens. 2012;30(1):168-76.
 

© REDISSEC 2013. All rights reserved.

Valid XHTML 1.0 Strict ¡CSS Válido! Icono de conformidad con el Nivel Doble-A, de las Directrices de Accesibilidad para el Contenido Web 1.0 del W3C-WAI